- Home
- SAND vs CERT Comparison
SAND vs CERT Comparison
Compare SAND & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAND
- CERT
- Stock Information
- Founded
- SAND 2007
- CERT 2008
- Country
- SAND Canada
- CERT United States
- Employees
- SAND N/A
- CERT N/A
- Industry
- SAND
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SAND
- CERT Technology
- Exchange
- SAND NYSE
- CERT Nasdaq
- Market Cap
- SAND 1.8B
- CERT 1.6B
- IPO Year
- SAND N/A
- CERT 2020
- Fundamental
- Price
- SAND $5.82
- CERT $9.77
- Analyst Decision
- SAND Buy
- CERT Buy
- Analyst Count
- SAND 3
- CERT 7
- Target Price
- SAND $9.33
- CERT $15.92
- AVG Volume (30 Days)
- SAND 3.6M
- CERT 1.1M
- Earning Date
- SAND 11-07-2024
- CERT 11-06-2024
- Dividend Yield
- SAND 0.97%
- CERT N/A
- EPS Growth
- SAND 142.46
- CERT N/A
- EPS
- SAND 0.12
- CERT N/A
- Revenue
- SAND $173,381,000.00
- CERT $372,797,000.00
- Revenue This Year
- SAND $1.65
- CERT $10.39
- Revenue Next Year
- SAND $15.64
- CERT $10.57
- P/E Ratio
- SAND $48.76
- CERT N/A
- Revenue Growth
- SAND N/A
- CERT 5.62
- 52 Week Low
- SAND $3.96
- CERT $9.41
- 52 Week High
- SAND $6.50
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- SAND 49.85
- CERT 35.94
- Support Level
- SAND $5.34
- CERT $10.54
- Resistance Level
- SAND $6.38
- CERT $11.37
- Average True Range (ATR)
- SAND 0.19
- CERT 0.43
- MACD
- SAND -0.01
- CERT -0.07
- Stochastic Oscillator
- SAND 45.67
- CERT 18.37
About SAND SANDSTORM GOLD LIMITED
Sandstorm Gold Ltd provides financing to companies engaged in gold mining through the gold stream and royalty. Geographically, the company has operational footprints in North America, South & Central America, Africa, and Asia & Australia. The firm's royalties include Hod Maden, Santa Elena, Chapada, Platreef, Greenstone, and Cerro Moro.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.